
Frontline Plc
FRO
Updated: 22/09/2026, 12:43:04
Frontline plc, a shipping company, engages in the ownership and operation of oil and product tankers worldwide. The company owns and operates oil and product tankers, such as very large crude carriers (VLCCs), Suezmax tankers, and LR2/Aframax tankers. As of December 31, 2025, it operated a fleet of 80 vessels, including 41 VLCCs, 21 Suezmax tankers, and 18 LR2/Aframax tankers. The company is also involved in the charter, purchase, and sale of vessels. Frontline plc was founded in 1985 and is based in Limassol, Cyprus.
No summaries found.
- Share price
- $49.81
- Market cap
- $11.09B
- Exchange
- NYSE
- Currency
- USD
- CEO
- Lars H. Barstad
- Employees
- 85
- IPO date
- 06/08/2001
- Beta
- 0.054
- Last dividend
- $0.00
- Day range
- $49.52 – $52.49
- 52-week range
- $20.47 – $54.91
- 1-day performance
- -3.13%
- 1-year performance
- 143.33%
- Current drawdown (1Y)
- -9.29%
- CIK
- 0000913290
- CUSIP
- G3682E192
- ISIN
- CY0200352116
- Created
- 07/12/2025, 04:05:09
- Last update
- 22/09/2026, 12:43:04
Track Frontline Plc with an AI analyst
See which prediction-market events move FRO, how its filings map to real-world exposure, and what 12 AI strategies are doing with positions like it.
Free forever to follow AlphaBrain’s AI strategies. No card required.
Crude Oil Slips Below $90—Yet These 4 Tanker Stocks Reach Top-Tier Momentum Zones
Benzinga • STOCK • 12/06/2026, 06:21:44
Frontline: A Market Squeeze Is Looking More And More Likely
Seeking Alpha • STOCK • 09/06/2026, 11:33:56
Frontline PLC (FRO) Shares Fall 3.0% -- What GF Score of 67 Tells Investors
GuruFocus • STOCK • 27/05/2026, 21:41:00
Frontline (FRO): Strong Q1, But Valuation Concerns Loom
Market Data • Market Data • 26/05/2026, 02:01:14
Frontline plc (NYSE:FRO) Navigates "Unprecedented Times" with Strong Q1 Financial Results
Market Data • Market Data • 23/05/2026, 02:00:13
Frontline plc (FRO) Q1 2026 Earnings Call Transcript
Seeking Alpha • STOCK • 22/05/2026, 13:40:43
Frontline Q1 Earnings Call Highlights
MarketBeat • STOCK • 22/05/2026, 13:10:18
Black Diamond Therapeutics Announces Positive Phase 2 Results for Silevertinib in Frontline NSCLC Patients with EGFR Non-Classical Mutations
GlobeNewsWire • STOCK • 21/05/2026, 19:13:00
Aptevo Reports 87% Clinical Benefit and 81% Remission in 31 Evaluable Frontline AML Patients Through Cohort 5, Substantially Outperforming Benchmark; RAINIER on Track for 2026 Completion and Phase 2 Dose Selection
Accesswire • STOCK • 06/05/2026, 10:05:00
Frontline: Why High Rates Will Last - Initiating Strong Buy
Seeking Alpha • STOCK • 27/04/2026, 17:05:08
Relay Therapeutics Announces Clinical Data for Zovegalisib plus Atirmociclib Triplet Combination Supportive of Further Development in Frontline Metastatic Breast Cancer
GlobeNewsWire • STOCK • 27/04/2026, 08:00:00
Frontline Education Accelerates AI Innovation Across K-12 with New Advisory Council and Strategic Partnership
GlobeNewsWire • STOCK • 22/04/2026, 10:01:00